Citadel Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Buy
400,700
+85,000
+27% +$640K ﹤0.01% 5708
2025
Q4
$2.26M Buy
315,700
+28,100
+10% +$222K ﹤0.01% 5679
2025
Q3
$3.07M Sell
287,600
-207,500
-42% -$2.04M ﹤0.01% 5272
2025
Q2
$4.79M Buy
495,100
+129,700
+35% +$1.34M ﹤0.01% 4181
2025
Q1
$5.44M Buy
365,400
+215,900
+144% +$3.32M ﹤0.01% 3731
2024
Q4
$2.23M Sell
149,500
-77,800
-34% -$1.27M ﹤0.01% 5403
2024
Q3
$4.35M Sell
227,300
-91,000
-29% -$1.89M ﹤0.01% 4174
2024
Q2
$6.59M Sell
318,300
-200
-0.1% -$3.98K ﹤0.01% 3342
2024
Q1
$5.99M Sell
318,500
-76,000
-19% -$1.3M ﹤0.01% 3656
2023
Q4
$5.69M Buy
394,500
+79,200
+25% +$1.08M ﹤0.01% 3604
2023
Q3
$5.47M Buy
315,300
+35,400
+13% +$738K ﹤0.01% 3517
2023
Q2
$5.82M Buy
279,900
+44,600
+19% +$969K ﹤0.01% 3413
2023
Q1
$5.53M Sell
235,300
-61,720
-21% -$1.66M ﹤0.01% 3640
2022
Q4
$8.3M Buy
297,020
+80,580
+37% +$2.06M ﹤0.01% 3078
2022
Q3
$5.07M Buy
216,440
+24,010
+12% +$725K ﹤0.01% 3844
2022
Q2
$6.5M Sell
192,430
-48,500
-20% -$1.7M ﹤0.01% 3341
2022
Q1
$8.42M Sell
240,930
-141,130
-37% -$4.83M ﹤0.01% 3244
2021
Q4
$11.6M Sell
382,060
-30,360
-7% -$989K ﹤0.01% 2807
2021
Q3
$13.5M Buy
412,420
+187,800
+84% +$6.01M ﹤0.01% 2588
2021
Q2
$6.8M Buy
+224,620
New +$7.39M ﹤0.01% 3801

Other funds holding OGN

Citadel Advisors's OGN Position: Q1 2026 in Review

Citadel Advisors reduced its Organon & Co (OGN) stake by 3.1% in Q1 2026, selling an estimated $486K and leaving 1,998,390 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Citadel Advisors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $116M in Q1 2024. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Citadel Advisors held 1,998,390 shares of Organon & Co worth $12M as of Q1 2026.
  • Citadel Advisors sold 64,584 Organon & Co shares in Q1 2026, an estimated $486K.
  • Organon & Co made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3008 holding.
  • Citadel Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Organon & Co position peaked at $116M in Q1 2024.
  • 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.